Structures Facilitate On-site Immediate
Coronavirus Testing
SG Blocks, Inc. (NASDAQ: SGBX), a leading designer, innovator
and fabricator of container-based structures, today announced the
D-Tec suite of prefabricated health facilities created in
partnership with Grimshaw and OSANG Healthcare for on-site
immediate COVID-19 testing. The D-Tec suite is designed to meet an
urgent global demand for safe, easily deployable medical response
solutions.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200528005231/en/
Example of a modular shipping container
repurposed as walk-in medical clinic (Photo: Business Wire)
This deployable technology line upcycles disused shipping
containers as a foundation for a sturdy and sustainable solution to
mass testing needs. Its design offers a safe, efficient environment
for testing collection and onsite deployable laboratory
analysis.
Paul Galvin, Chairman and CEO of SG Blocks, Inc. commented
“Grimshaw’s commitment to human centric design combined with
OSANG’s extremely accurate tests should enable SG Blocks to create
turnkey testing facilities throughout the USA to provide access to
the greatest number of people without compromising the needs of
staff or users. We can think of no better partners to help
supplement the existing health care system.”
Andrew Whalley, Grimshaw chairman states “Grimshaw recognizes
the important role that a rapidly deployable solution has in
opening up greater access to testing that people can trust and rely
on. We have always aimed to deliver progressive architecture that
strives for a better future, and we believe this suite of highly
adaptable, efficient building solutions developed by our Industrial
Design team will provide greater opportunities for the critical
role testing, and people’s trust in testing sites, will play as we
move forward.”
Dong-Hyun Lee, Chairman & Chief Executive Officer of OSANG
Healthcare Co., Ltd. stated, “We view SG Blocks and Grimshaw as
ideal partners to broaden distribution of our advanced tests and
expand our ability to directly address this global pandemic in the
USA. Our pipeline is substantial, we believe Grimshaw’s commitment
to sustainable, flexible design solutions combined with SG Blocks
modular construction expertise has the ability to address
logistical challenges.”
The first prototypes, slated for completion in June, will offer
ample space for social distancing, access to hand-washing stations
and a purified air system so medical professionals and patients can
be confident their health and well-being is protected throughout
their visit. Other features will include physical separation
between medical staff and patients, contact-less testing, walk-up
windows, and rapid, on-site sample processing.
About SG Blocks, Inc. SG Blocks,
Inc. is a premier innovator in advancing and promoting the use of
code-engineered cargo shipping containers for safe and sustainable
construction. The firm offers a product that exceeds many standard
building code requirements, and also supports developers,
architects, builders and owners in achieving greener construction,
faster execution, and stronger buildings of higher value. Each
project starts with GreenSteel™, the structural core and shell of
an SG Blocks building, and then customized to client
specifications. For more information, visit www.sgblocks.com.
About Grimshaw Grimshaw was founded
by Sir Nicholas Grimshaw in 1980. The practice operates worldwide,
across all major sectors, with offices in London, Paris, New York,
Los Angeles, Dubai, Melbourne and Sydney, employing over 650 staff.
Grimshaw has been honoured with over 200 awards for its commitment
to excellence and innovation, including ‘Practice of the Year’ and
‘Building of the Year’ at the 2019 AJ100. In 2019, Founder Sir
Nicholas Grimshaw was awarded the Royal Gold Medal for Architecture
by the Royal Institute of British Architects.
www.grimshaw.global
About OSANG Healthcare Co., Ltd.
OSANG Healthcare is a South Korea based global manufacturer and
distributor of medical devices and in-vitro diagnostics solutions.
Devoted since inception to the development of diagnostic biosensors
for blood glucose measurement, OSANG Healthcare envisions medical
devices becoming as commonplace as home appliances, easily
measuring all diseases across the globe as “Technology for Human”.
OSANG Healthcare currently exports its diagnostic biosensors for
blood glucose, HbA1c and cholesterol to more than 110 countries, in
its drive to become the leading researcher and developer of
diagnostic sensors for heart disease and cancer, and of remote
diagnosis systems. For more information, visit
www.osanghc.com.
Forward-Looking Statements Certain
statements in this press release constitute "forward-looking
statements" within the meaning of the federal securities laws.
Words such as "may," "might," "will," "should," "believe,"
"expect," "anticipate," "estimate," "continue," "predict,"
"forecast," "project," "plan," "intend" or similar expressions, or
statements regarding intent, belief, or current expectations, are
forward-looking statements. These forward-looking statements are
based upon current estimates and assumptions and include statements
regarding creating turnkey testing facilities throughout the USA to
provide access to the greatest number of people without
compromising the needs of staff or users, the suite of building
solutions developed by Grimshaw’s Industrial Design team providing
greater opportunities for the critical role testing, and people’s
trust in testing sites, will play in the future, Grimshaw’s
commitment to sustainable, flexible design solutions combined with
SG Blocks modular construction expertise having the ability to
address logistical challenges and the first prototypes being slated
for completion in June. While SG Blocks believes these
forward-looking statements are reasonable, undue reliance should
not be placed on any such forward-looking statements, which are
based on information available to us on the date of this release.
These forward-looking statements are subject to various risks and
uncertainties, many of which are difficult to predict that could
cause actual results to differ materially from current expectations
and assumptions from those set forth or implied by any
forward-looking statements. Important factors that could cause
actual results to differ materially from current expectations
include, among others, the Company’s ability to create turnkey
testing facilities throughout the USA to provide access to the
greatest number of people without compromising the needs of staff
or users, the ability of the suite of building solutions developed
by Grimshaw’s Industrial Design team to provide greater
opportunities for the critical role testing, and people’s trust in
testing sites, will play in the future, the Company’s and
Grimshaw’s ability to complete the first prototypes slated for
completion in June and address logistical challenges, the Company’s
ability to position itself for future profitability, the Company’s
ability to maintain compliance with the NASDAQ listing
requirements, and the other factors discussed in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2019 and
the Company’s subsequent filings with the SEC, including subsequent
periodic reports on Forms 10-Q and 8-K. The information in this
release is provided only as of the date of this release, and the
Company undertakes no obligation to update any forward-looking
statements contained in this release on account of new information,
future events, or otherwise, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200528005231/en/
Media Rubenstein Public Relations Christina Levin Account
Director 212-805-3029 clevin@rubensteinpr.com
or
Investor Relations James Carbonara Hayden IR (646) 755-7412
james@haydenir.com
Brett Maas Hayden IR (646) 536-7331 brett@haydenir.com
Safe and Green (NASDAQ:SGBX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Safe and Green (NASDAQ:SGBX)
Historical Stock Chart
From Sep 2023 to Sep 2024